glp-1 weight loss drug news today october 2025 Rhode Island considers ending Medicaid coverage of drugs for • Rhode Island Current How to Invest in GLP-1

Neuroprotective Effects of GLP-1 Receptor Agonists in Neurodegenerative Disorders: A Large-Scale Propensity-Matched Cohort Study

Sokos GG, Bolukoglu H, German J, Hentosz T, Magovern GJ, Maher TD, Dean DA, Bailey SH, Marrone G, Benckart DH, Elahi D, Shannon RP: Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting

Every bite needs to be nutritious, Christen said

PMID: 33714600

Given the shift towards pharmaceutical intervention in obesity management, GLP-1 therapies are expected to account for a substantial share of this growth

doi: 10.1016/j.metabol.2020.154272 25 CarusoICignarelliALaviolaLGiorginoF